Weight-loss injections are influencing consumer spending habits across various sectors. Research by University College London indicates that approximately 1.6 million people in the UK used weight-loss jabs in 2024, with potential for further adoption.
These drugs, which mimic the hunger-regulating hormone GLP-1, reduce appetite and impact purchasing patterns.
Grocery Spending
Individuals using weight-loss jabs report reduced weekly food expenditures. They prioritize fresh, nutrient-dense foods and fewer unhealthy ready-meal options.
Major supermarkets such as The Co-op, Morrisons, and Marks and and Spencer have introduced nutrient-dense ready meal ranges. Ocado has responded to customer demand for smaller portions, offering items like a 100g steak. The shift also includes increased availability of protein-rich products, aligning with a broader consumer trend toward health and well-being.
Dining Out
Surveys indicate that nearly a third of GLP-1 drug users reduce their frequency of eating out and ordering takeaways.
This trend has led some establishments, including the bakery chain Greggs and the Michelin-starred restaurant The Fat Duck, to adapt by offering smaller portions or menus designed for